LONGBOARD PHARMACEUTICALS IN (LBPH) Institutional Ownership
None of the superinvestors we track currently report LONGBOARD PHARMACEUTICALS IN (LBPH) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in LONGBOARD PHARMACEUTICALS IN (LBPH), this page will show fund ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q3 2024 | 1 | $65,628,137 | 1,969,041 |
| Q2 2024 | 1 | $44,841,743 | 1,658,962 |
| Q1 2024 | 2 | $21,198,227 | 1,052,728 |
| Q2 2023 | 1 | $115 | 15,700 |
| Q2 2021 | 1 | $95 | 10,400 |
Related LBPH Institutional Insights:
- LBPH Institutional Ownership & Insiders Activity
- LBPH Institutional Ownership & 13F Activity
- LBPH Top Institutional Shareholders
- LBPH Institutional Buying Activity
- LBPH Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- LBPH Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings